Astrazeneca
May 18, 2012 at 11:55 | Source: Moneycontrol.com
May 16, 2012 at 12:24 | Source: Moneycontrol.com
May 15, 2012 at 15:50 | Source: Moneycontrol.com
Apr 16, 2012 at 11:29 | Source: CNBC-TV18
Mar 29, 2012 at 15:36 | Source: Moneycontrol.com
News across the web »
May 26, 2012 at 08:21 | Source: Forbes
May 23, 2012 at 11:57 | Source: FirstPost
May 21, 2012 at 13:38 | Source: Economic Times
May 18, 2012 at 22:51 | Source: FirstPost
May 18, 2012 at 22:51 | Source: FirstPost
Interact & exchange stock tips & market info »
Related News »
AstraZeneca Plc (AZN), the U.K.’s second- biggest drugmaker, shouldn’t get a further reduction for an antitrust fine of 52.5 million euros ($67.5 million), an adviser to the European Union’s highest court said. Jan Mazak, the advocate ...
May 15, 2012 at 10:25 | Source: Bloomberg
Crestor Benefit Program now covers the difference in cost between generic & brand HALIFAX, May 29, 2012 /CNW/ - Canadian pharmaceutical manufacturer, AstraZeneca, modifies the recently launched Crestor Prescription Benefit cards to cover the difference in ...
May 29, 2012 at 11:48 | Source: Phramalive.com
New York, May 29th (TradersHuddle.com) - Shares of AstraZeneca PLC (NYSE:AZN) finished near calculated support at $40.76. The London, England based biopharmaceutical company closed at $41.23 leaving shares at a level that will spark interest by traders ...
May 29, 2012 at 12:17 | Source: TradersHuddle.com
AstraZeneca has been under pressure for a while to improve its drugs pipeline by splashing out on major acquisitions, but analyst at Societe Generale are suggesting the company might do better to shrink down. Astra recently announced that chief executive ...
May 28, 2012 at 10:09 | Source: The Guardian
AstraZeneca plans to seal several new deals this year to fill its flagging pipeline of experimental medicines, which may be funded jointly with private investors. Martin Mackay, president of research and development at the Anglo-Swedish pharmaceutical ...
May 20, 2012 at 20:06 | Source: Financial Times
AstraZeneca PLC (AstraZeneca) is a leading pharmaceutical company. The company discovers, develops, produces and markets a broad range of biologics, prescription pharmaceuticals and vaccines for the treatment of diseases such as cancer, cardiovascular ...
May 20, 2012 at 16:31 | Source: Transworld News
AstraZeneca PLC (>> AstraZeneca plc) said Monday it bought 130,000 of its own ordinary shares of AstraZeneca at 2609 pence per share to cancel. -Shares at 0745 GMT up 23 pence, or 1%, at 2655 pence valuing the company at GBP33.6 billion. -By Ed Ballard ...
May 28, 2012 at 08:15 | Source: 4-traders (press release)
AstraZeneca isn't wasting any time in pushing ahead with draconian cuts to its neuroscience work in its big R&D hub south of Stockholm. The first 50 scientists have already been shown the door, according to local news reports, part of the first ...
May 14, 2012 at 23:55 | Source: FierceBiotech
Amylin Pharmaceuticals, the US maker of diabetes-focused medicines, has attracted a string of potential suitors, including Anglo-Swedish group AstraZeneca, people close to the situation said. The move comes amid a flurry of M&A activity in the sector ...
May 15, 2012 at 18:17 | Source: Financial Times